INS and Insulin resistance: In STEMI patients, the SIH primarily arises from β-cell dysfunction and insulin resistance (28, 29), on the one hand, pancreatic β-cell dysfunction impairs insulin release and reduces proinsulin concentration, while the sympathetic nervous system activation increases glucagon, cortisol, and cytokines, thereby stimulating glucose production through increased gluconeogenesis and glycogenolysis (28).